Centene (CNC) is trading lower as the market continues to digest and extend a selloff tied to weakening visibility in its Affordable Care Act (ACA) marketplace business. Recent investor focus has centered on management’s disclosure that ACA exchange membership dropped to roughly 3.6 million as of February 2026 from 5.5 million at the end of 2025—a steep decline that has revived concerns about revenue headwinds, risk-pool deterioration, and earnings volatility even if per-member profitability improves.

At an industry conference, CEO Sarah London indicated the ACA membership decline was broadly in line with expectations, but the magnitude of the early-year drop has kept the debate active over how quickly Centene can stabilize marketplace performance. Investors are weighing whether aggressive repricing and plan mix shifts can protect margins while still keeping enough scale to manage medical cost risk, particularly as the broader ACA market adapts to changes in subsidy support and enrollment dynamics.

While Centene has reiterated its 2026 earnings framework—reaffirming adjusted diluted EPS guidance of greater than $3.00—today’s move reflects skepticism that the company can execute cleanly through the 2026 plan year with materially lower marketplace membership. The stock’s decline suggests investors want clearer evidence that membership stabilization, medical cost trend control, and marketplace risk adjustment outcomes will align with the company’s targets.

Near-term, traders are likely to monitor additional membership updates, any further commentary on marketplace attrition and metal-tier mix, and signs of spillover into Medicaid profitability. The next major catalyst is upcoming quarterly reporting and management commentary that can confirm whether early-year enrollment and medical utilization trends are tracking the assumptions embedded in Centene’s 2026 outlook.